Nutriband (NTRB) to Release Quarterly Earnings on Monday

Nutriband (NASDAQ:NTRB) will likely be issuing its results after the market closes on Monday, April 27th. Analysts expect the company to announce earnings of ($1.89) per share and revenue of $0.7650 million for the quarter.

Nutriband Stock Performance

Nutriband stock opened at $4.30 on Monday. The stock has a market cap of $52.37 million, a P/E ratio of -1.40 and a beta of 1.92. The company has a current ratio of 7.52, a quick ratio of 7.35 and a debt-to-equity ratio of 0.01. The stock has a 50 day moving average of $4.03 and a 200-day moving average of $4.95. Nutriband has a 52 week low of $3.42 and a 52 week high of $11.68.

Hedge Funds Weigh In On Nutriband

A hedge fund recently raised its stake in Nutriband stock. Vanguard Group Inc. grew its holdings in shares of Nutriband Inc. (NASDAQ:NTRB) by 1.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 202,738 shares of the company’s stock after buying an additional 3,111 shares during the quarter. Vanguard Group Inc. owned 1.68% of Nutriband worth $1,429,000 as of its most recent SEC filing. Institutional investors own 19.70% of the company’s stock.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.